Addiction & Substance Use

We may be one step closer to nonprescription naloxone.

How can PMHNP consults with law enforcement reduce involuntary transfers and other unwanted outcomes?

What is recovery?

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

Fentanyl is now available in ways it was not before, which may lead to fatal outcomes.

Opioid use, addiction, and overdose in youth continue to increase. What can be done?

A review of the Joint US-Canada Report on Substance Use and Harm.

The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.

As Suicide Prevention Month continues, we take a look at the mental health of a group constantly caring for others: first responders.

Contingency management is an effective behavior change technique commonly used to treat substance use disorders.

A new study finds mood shifts and alcohol-related cues affect men and women differently in terms of alcohol cravings.

A psychiatrist reflects on how we can educate patients about avoiding alcohol misuse without getting caught up in polemics on politics.

Suicide Prevention Week is September 4-10. Are you ready?

New data shows a decrease in life expectancy in the United States. Here’s why.

The experts weighed in on a wide variety of psychiatric issues for the August 2022 issue of Psychiatric Times.

“Doctors are great at hiding their addictions, especially from themselves... However, there are signs that something is wrong—be it addiction, depression, psychosis, or some other problem.”

Opioid use disorder—how can we battle the epidemic of overdoses?

Medication, counseling, and support—just as important in substance use disorder treatment as any other brain disease.

Cannabis use disorder and nonadherence: How can we best educate patients?

The experts weighed in on a wide variety of psychiatric issues for the July 2022 issue of Psychiatric Times.

Positive results from the phase 3 trial of AD04 show a 79% reduction in heavy drinking.

What happens when a clinician is faced with addiction in their own family?

New results are coming for AD04, a potential treatment for patients with alcohol use disorder.

Treatment deserts are adding fuel to the fire of the opioid crisis.